Amr Soliman, M.D, Ph.DCEESP Director & Medical Professor
Robert Chamberlain, PhDCEESP Co-Investigator & Professor Emeritus
Joan Dorn, Ph.DChair and Medical Professor
Marlene Camacho-Rivera, ScD, MPHAssistant Medical Professor
Erica Lubetkin, MDAssociate Medical Professor
Tashuna Albritton, Ph.DAssistant Medical Professor
Victoria Frye, DrPHAssociate Medical Professor
Amr Soliman, M.D, Ph.D
Over the past 25 years, Dr. Amr Soliman has been collaborating with faculty in Africa, the Middle East, and minority populations in the U.S. to develop a program in international cancer epidemiology and migration studies. This has led to a strong research infrastructure with several centers in Africa to investigate the epidemiology of colorectal, cervical, and breast cancers. The U54 research training program that he has led in Tanzania and the inflammatory breast cancer research study that he leads in North Africa are major components of his research that provides significant opportunities for research training of students of the NCI-funded R25 Cancer Epidemiology Education in Special Populations (CEESP) program. The CEESP program was funded from the NCI in 2006 and is continuing through the current third 5-year grant cycle that ends in 2021. Dr. Soliman has also conducted collaborative research with the minority-focused SEER registry in Detroit, the Michigan Cancer Consortium, the State Cancer Registry of Michigan, and the Arab American Center for Social and Economic Services in Dearborn, Michigan. He has also established research studies with the African and Asian refugees in Nebraska and with minority populations in Omaha and Lincoln, Nebraska. His research mentoring experience includes working with trainees from minority and underserved populations. His research also includes access to cancer care, screening, and early detection in these populations.
Robert Chamberlain, PhD
I serve on this CEESP grant because of my expertise in cancer education, research training, and epidemiologic research in minority and underserved settings. I served on the NCI review group, Subcommittee G for many years, and most recently was Chair. I am a Fellow and Past-President of the American Association for Cancer Education. I led the University of Texas M.D. Anderson Cancer Research Training Program, with support from NCI R25E and R25T grants for 18 years until my retirement in 2012. I have worked closely with Dr. Soliman on the CEESP program from its beginning at the University of Michigan, at the University of Nebraska, now at CUNY. I have chaired the Advisory Committee (AC) of the CEESP program over the past 10 years. In 2005, I was selected as a charter member of the University of Texas Academy of Health Science Education. In 2006, the American Association for Cancer Education honored me with their highest award; the Margaret Hay Edwards Medal for outstanding contributions in cancer education. In research, I have developed educationally based recruitment strategies for chemoprevention trials and I was member of the Outcomes Committee of the Radiation Therapy Oncology Group (RTOG) that is involved with most of the group’s trials. I have mentored many trainees in their research, particularly in molecular, genetic, and social epidemiology, including many CEESP students.
Joan Dorn, Ph.D
Dr. Dorn’s came to CUNY Medical School in November 2014 after serving as Chief of the Physical Activity and Health Branch in the Division of Nutrition, Physical Activity and Obesity at the Centers for Disease Control and Prevention. Prior to that Dr. Dorn served as Professor and Chair of the Department of Exercise and Nutrition Sciences and Research Professor in the Department of Social and Preventive Medicine in the School of Public Health and Health Professions at the State University of New York, University at Buffalo. Dr. Dorn’s research interests include health equity in underserved populations and the role of physical activity and other lifestyle behaviors in the primary and secondary prevention of chronic diseases, particularly cardiovascular diseases and obesity research. Dr. Dorn is a member of the research committee of the International Cancer Prevention Consortium (ICPC) that is focused on research and capacity building for cancer prevention and control in Africa and the Middle East.
Marlene Camacho-Rivera, ScD, MPH
Dr. Marlene Camacho-Rivera is an Assistant Medical Professor in the department of Community Health and Social Medicine at the CUNY School of Medicine. An epidemiologist by training, Dr. Camacho-Rivera’s research focuses on three main themes:
- Elucidating social determinants of racial/ethnic disparities in chronic diseases such as asthma and cancer
- Exploring within group heterogeneity in the prevention and treatment of chronic disease outcomes among racial/ethnic groups
- Developing culturally-tailored, patient-centered interventions to improve chronic disease self-management among urban minorities
Dr. Camacho-Rivera’s recent publications have focused on frequency of surgery in Black patients with malignant pleural mesothelioma, average values and racial differences of neutrophil lymphocyte ratio among a nationally representative sample of United States subjects, heterogeneity of breast cancer clinical characteristics and outcomes in US Black women, and effect of place of birth and gender difference on survivorship after malignant pleural mesothelioma diagnosis. Her current research focuses on racial and ethnic differences in cancer-related health information seeking behaviors and use of new technologies to support health-related decision making.
Erica Lubetkin, MD
Dr. Lubetkin’s publications have focused on health literacy and information in Haitians, examining intuitive cancer risk perceptions in Haitian- Creole and Spanish populations, promoting cancer prevention and control in community-based HIV/AIDS service organizations, differences in patient activation across new immigrant, diverse language subgroups, and the intersection of HIV/AIDS and cancer. She also has published extensively on patient-reported outcomes, particularly, health-related quality of life, and measuring the burden of disease due to chronic diseases and health risk behaviors. She currently serves as the chair of an international health inequalities special interest group (through the EuroQol Group) and a member of the Large Scale Applications (LSA) Working Group
Tashuna Albritton, Ph.D
Dr. Albritton is an Assistant Medical Professor in the Department of Community Health and Social Medicine. Dr. Albritton has extensive training in community-based behavioral intervention research, particularly with minority populations, in both urban and rural communities. She completed a 3-year postdoctoral fellowship at the Yale University Center for Interdisciplinary Research on AIDS and School of Public Health. Her research focuses on sexually transmitted infections and HIV prevention intervention among African American adolescents. She also examines the individual, interpersonal, community and environmental level factors that influence risk and protective behaviors. The scope of Dr. Albritton’s research includes adolescent sexual and reproductive health and health services, HIV/AIDS and sexually transmitted infections prevention interventions, urban and rural sexually transmitted infections disparities, community health, community-based participatory research, and social technology innovation and intervention research.
Victoria Frye, DrPH
Dr. Frye arrived at the CUNY School of Medicine/Sophie Davis Program in Biomedical Education in late 2015, after serving as the Head of the Laboratory of Social and Behavioral Sciences at the New York Blood Center and as an Assistant Professor of Clinical Sociomedical Sciences at Columbia University’s Mailman School of Public Health. Dr. Frye’s research combines epidemiological and social science theories and methods to study the distribution, determinants and health consequences of intimate partner and sexual violence and HIV/AIDS. Additionally, she designs and tests multi-level and multi-component interventions to prevent HIV and violence. Dr. Frye is currently the PI of two NIH-funded studies. The first (R21/AI-122996) assesses barriers to and facilitators of uptake of non-occupational post-exposure HIV prophylaxis (“PEP”) use among Black and Latino men who have sex with men (MSM) and transgender women living in upper Manhattan and the Bronx; the goal of the study is to inform the development and evaluation of a social and print media campaign to drive demand for PEP. The second, a randomized, controlled clinical trial (R01/DA-038108), assesses the impact of a behavioral intervention on uptake of consistent HIV self-testing among young, Black MSM and transgender women. Dr. Frye recently completed work on a NIMH-funded study (R21/MH-102182-01) to design and test a community-level anti-HIV stigma and homophobia intervention, Project CHHANGE (“Challenge HIV Stigma and Gain Empowerment”). She is a co-investigator on three additional NIH-funded studies, including another RCT on HIV testing among MSM (1R01/HD-078595-01), an observational mixed methods study examining neighborhoods influence on HIV among MSM (R56/MH-110176), and an RCT of an intervention to increase blood donation among young first-time donors (1R01/HL-127766). In 2006, Dr. Frye received a mentored career development award from NIDA (K01 DA-020774) and her research has been published in JAMA, American Journal of Public Health, Social Science and Medicine, JAIDS, AIDS and Behavior, AIDS Care, Violence against Women, Journal of Community Psychology, Journal of Interpersonal Violence, and the Journal of Urban Health, where she serves as an Associate Editor.